Product Images Desmopressin Acetate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Desmopressin Acetate NDC 70518-3125 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

MM2 - Desmopressin Acetate 0.2mg 70518 3125 01

MM2 - Desmopressin Acetate 0.2mg 70518 3125 01

Desmopressin Acetate is a prescription medication manufactured by Glenmark, Mahwah, NJ 07430. It is repackaged by RemedyRepack Inc., Indiana, PA 15701, and should be stored at 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. Lot and expiration information can be found on the packaging. The package insert should be consulted for directions on use. It is important to keep this medication away from children.*

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Desmopressin Acetate is a prescription medication manufactured by Glenmark and packaged by RemedyRepack Inc. It is intended for use as directed and should be kept out of reach of children. The NDC number for this product is 70518-3125-00 and the lot number and expiration date should be checked before use. The medication should be stored at 20-26°C with excursions allowed to 15-30°C, and the package insert should be consulted for directions.*

structure - structure

structure - structure

This is a chemical compound with a molecular weight of 1129.27 and an empirical formula of G,H,N,O,S. Its structural formula consists of amino acids SCH, CH, C-Tyr-Phe-GIn-Asn-Cys-Pro-D-Arg-Gly-NH2CH2COOH with 1-(3-mercaptopropanoic acid)-8-D-arginine vasopressin monoacetate (salt) as its name. The numbers 1-9 are associated with each amino acid in order. The first line of text might be a description of a related compound. The second line is not legible.*

table-1 - table 1

table-1 - table 1

This text provides mean changes from baseline in pharmacodynamic parameters in normal healthy adult volunteers for different treatments. The treatments include various dosages and modes of administration (oral or intranasal) of an unspecified medication. The pharmacodynamic parameters measured were total urine volume in mL and maximum 'gli]i:re"?ksgmnlalily in 0.1 mg. Standard error of the mean is also provided for each measurement.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.